We improve patient lives by unlocking the tissue phenome.

In oncology, therapeutic strategies have shifted from a direct assault on cancer cells to recruiting the immune system for that purpose. Our mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer-relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies. Our vision is to create unique patient profiles for an individualized standard of care, where patients experience fewer side effects and live longer.

Definiens' Tissue Phenomics approach was awarded the 2013 Frost and Sullivan Company of the Year Award for Global Tissue Diagnostics and Pathology Imaging. For more information, please visit: www.definiens.com.

Do you want to share our pioneering vision and be part of this significant approach?

Current Job Openings at Definiens

Administration

Executive Assistant (m/f)
Definiens AG Munich

HR

Medical

Product Development

Head of Quality Assurance (m/f)
Definiens AG Munich
Software Developer C++ (m/f)
Definiens AG Munich

Product Marketing

Professional Services

Professional Services Manager
Definiens AG Munich
Project Manager (m/f)
Definiens AG Munich

Research

Sales

Software Operations

Share this page: